Transcriptomic and functional responses of the cystic fibrosis airway epithelium to CFTR modulator therapy
JCI Insight · 2025
DOI: 10.1172/jci.insight.196018 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2025. Verfasst von Eszter K Vladar und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Colorado, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Quinolones, Aminophenols. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Cystic Fibrosis Foundation, Marshall and Margherite McComb Foundation.
Abstract (Originalsprache)
Elexacaftor/tezacaftor/ivacaftor (ETI) cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy has led to rapid and substantial improvements in cystic fibrosis (CF) airway disease. Underlying molecular and cellular mechanisms, long-term efficacy, and ability to reverse airway epithelial remodeling in established disease remain unclear. Longitudinal nasal brushes from an adult CF cohort were used to evaluate gene expression, cellular composition, stem cell function, and microbiome changes at baseline and at 6 months and 2 years after ETI. The baseline to 6 month span showed a massive downregulation of extensive neutrophilic inflammatory gene expression programs that correlated with increased pulmonary function and decreased sinusitis. Primary airway epithelial stem cell cultures from matched donor samples showed partially improved differentiation and barrier capacity at 6 months. Although clinical outcomes remained stable during the 6 month to 2 year span, transcriptional changes revealed a resurgence of baseline inflammatory programs. The time course of gene expression was consistent with ongoing normalization of epithelial remodeling. Relative abundance of Pseudomonas also decreased during the time course. These data suggest that ETI rectifies inflammation, epithelial remodeling, and bacterial infection in the airways, but resurgence of inflammatory gene expression may indicate ongoing inflammation, potentially presaging disease progression with long-term therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Colorado, Aurora, Colorado, USA.
- Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado, USA.
- Division of Biostatistics, National Jewish Health, Denver, Colorado, USA.
- Departments of Pediatrics, University of Colorado, Aurora, Colorado, USA.
- Center for Genes, Environment, and Health, and.
- Department of Pediatrics, National Jewish Health, Denver, Colorado, USA.
Förderung
- NHLBI NIH HHS
- Cystic Fibrosis Foundation
- Marshall and Margherite McComb Foundation
Zitieren
APA
Vladar, E. K., Gillen, A. E., Yadav, S., Murphree, M. R., Baraghoshi, D., Harris, J. K., Pruesse, E., Niemiec, S. S., Wilson, A. W., Hisert, K. B., Humphries, S. M., Strand, M., Lynch, D. A., Seibold, M. A., Beswick, D. M., & Taylor-Cousar, J. L. (2025). Transcriptomic and functional responses of the cystic fibrosis airway epithelium to CFTR modulator therapy. JCI Insight. https://doi.org/10.1172/jci.insight.196018
Vancouver
Vladar EK, Gillen AE, Yadav S, Murphree MR, Baraghoshi D, Harris JK, et al. Transcriptomic and functional responses of the cystic fibrosis airway epithelium to CFTR modulator therapy. JCI Insight. 2025. doi:10.1172/jci.insight.196018
BibTeX
@article{Vladar2025,
author = {Vladar, Eszter K and Gillen, Austin E and Yadav, Sangya and Murphree, Mikayla R and Baraghoshi, David and Harris, J Kirk and Pruesse, Elmar and Niemiec, Sierra S and Wilson, Alexandra Wm and Hisert, Katherine B and Humphries, Stephen M and Strand, Matthew and Lynch, David A and Seibold, Max A and Beswick, Daniel M and Taylor-Cousar, Jennifer L},
title = {Transcriptomic and functional responses of the cystic fibrosis airway epithelium to CFTR modulator therapy},
journal = {JCI Insight},
year = {2025},
doi = {10.1172/jci.insight.196018}
}
EUVIMED